Marrow Stem Cells Shift Gene Expression and Engraftment Phenotype with Cell Cycle Transit by Lambert, Jean-François et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2003/06/1563/10 $8.00
Volume 197, Number 11, June 2, 2003 1563–1572
http://www.jem.org/cgi/doi/10.1084/jem.20030031
 
1563
 
Marrow Stem Cells Shift Gene Expression and Engraftment 
Phenotype with Cell Cycle Transit
 
Jean-François Lambert,
 
1, 2
 
 Meng Liu,
 
3
 
 Gerald A. Colvin,
 
1
 
 Mark Dooner,
 
1
 
 
Christina I. McAuliffe,
 
1
 
 Pamela S. Becker,
 
5
 
 Bernard G. Forget,
 
4
 
Sherman M. Weissman,
 
4
 
 and Peter J. Quesenberry
 
1
 
1
 
Roger Williams Medical Center, Providence, RI 02908
 
2
 
Division of Hematology, University Hospital, CH1211 Geneva 14, Switzerland
 
3
 
Schepens Eye Research Institute, Harvard University, Boston, MA 02114
 
4
 
Department of Genetics, Yale University School of Medicine, New Haven, CT 06520
 
5
 
University of Massachusetts Cancer Center, Worcester, MA 01655
 
Abstract
 
We studied the genetic and engraftment phenotype of highly purified murine hematopoietic
stem cells (lineage negative, rhodamine-low, Hoechst-low) through cytokine-stimulated cell
cycle. Cells were cultured in interleukin (IL)-3, IL-6, IL-11, and steel factor for 0 to 48 h and
tested for engraftment capacity in a lethally irradiated murine competitive transplant model.
Engraftment showed major fluctuations with nadirs at 36 and 48 h of culture and recovery dur-
ing the next G1. Gene expression of quiescent (0 h) or cycling (48 h) stem cells was compared
with lineage positive cells by 3
 
 
 
 end PCR differential display analysis. Individual PCR bands
were quantified using a 0 to 9 scale and results were visually compared using color-coded ma-
trices. We defined a set of 637 transcripts expressed in stem cells and not expressed in lineage
positive cells. Gene expression analyzed at 0 and 48 h showed a major shift from “stem cell
genes” being highly expressed at 0 h and turned off at 48 h, while “cell division” genes were
turned on at 48 h. These observations suggest stem cell gene expression shifts through cell cycle
in relation to cell cycle related alterations of stem cell phenotype. The engraftment defect is re-
lated to a major phenotypic change of the stem cell.
Key words: stem • cell • gene • expression • cycle
 
Introduction
 
Hematopoietic stem cells, despite being undifferentiated,
can express specific stem cell functions, such as rapid hom-
ing to bone marrow (1, 2), cell surface molecule expression
(3, 4), rapid motility (5, 6), and settlement in their final en-
dosteal bone marrow niche (7). These cells are capable of
quasi-infinite self-renewal and have a tremendous differ-
entiation potential, a single to a few cells being capable of
repopulating the entire hematopoietic system of a lethally
irradiated recipient (8). Murine stem cells have been de-
fined based on their undifferentiated characteristics (i.e.,
lineage negativity), as well as specific positive markers, such
as Sca-1 and c-kit. Another approach was based on the rel-
ative quiescence of stem cells and used the DNA binding
dye Hoechst 33342 and the mitochondrial binding dye
rhodamine 123. Isolation was based on a negative lineage
selection using magnetic beads, followed by low Hoechst
and low rhodamine expression (LRH; references 9 and 10). 
Previous work with unseparated marrow has shown a loss
of engraftment potential when whole marrow was cultured
in cytokine cocktails such as IL-3, IL-6, IL-11, and Steel
 
factor (11, 12) or Flt3, TPO, and stem cell factor (SCF)
 
*
 
(13). This defect was reversible and cell cycle mapping de-
fined late S-early G
 
2
 
 as the lowest engraftment period. In
contrast to general dogma, primitive long-term renewing
stem cells are not quiescent. BRDU incorporation experi-
ments showed that more than 60% of stem cells had cycled
at least once within 4 wk (10, 14, 15). They probably enter
and exit cycle frequently, alternatively they may exist in a
prolonged G
 
1
 
 period. Furthermore, primitive stem cells are
easily induced into active cell cycle after either in vivo
transplantation or in vitro cytokine exposure (16, 17).
 
Address correspondence to Peter J. Quesenberry, Director, Department
of Research, Roger Williams Medical Center, 825 Chalkstone Ave.,
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Abbreviation used in this paper:
 
 SCF, stem cell factor (or steel factor).T
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Whole bone marrow stem cells probably cycle in an asyn-
chronous fashion. Hematopoietic stem cells, purified by the
Hoechst/rhodamine approach, are relatively quiescent, and
when exposed to cytokines show a highly synchronous pro-
gression through cell cycle (17). We have now studied the
engraftment function of highly purified LRH cells as they
transit through cell cycle under cytokine stimulation.
To identify specific cell cycle related changes that could
explain the engraftment defect, one needs to analyze in de-
tail the pattern of stem cell genes expressed in noncycling
and cycling cells. Using different sources of stem cells, sev-
eral groups described stem cell gene expression analysis us-
ing subtracted libraries and array technology. Phillips, et al.
(18) have reported on over 2,000 nonredundant gene
products from fetal liver hematopoietic stem cells using a
subtracted cDNA library to generate a micro array chip.
They have identified several genes specific to fetal liver he-
matopoietic cells. In addition, when comparing fetal he-
matopoietic cells with adult hematopoietic cells (Rho-
damine-123 low c-Kit
 
 
 
 Sca-1
 
 
 
) they found several genes
that were coexpressed in fetal and adult stem cells, as well
as genes specific for either fetal or adult stem cells. More
recently, gene expression profiling of human and murine
bone marrow, as well as other types of stem cells, has been
reported (19, 20). 
Park et al. (21) have also reported on murine hematopoi-
etic stem cell gene profiling. They used a 5,000 cDNA ar-
ray obtained by subtraction of cDNA from lineage positive
cell populations and studied both hematopoietic adult stem
cells and multipotent progenitors (with minimal self re-
newal capacity). Genes primarily expressed in stem cells
were transcription factors, RNA binding proteins, chroma-
tin modifiers, and protein kinases.
We have used differential display, which was developed
for comparative gene expression studies, and allows for a
systematic and nonbiased screening for molecular differ-
ences at the level of mRNA expression, between or among
different cells or tissues. The comparisons use a gel-based
method that employs the display of 3
 
 
 
 end fragments of
cDNA generated by cutting with specific restriction en-
zymes. The amplified cDNAs labeled with radioisotope are
then distributed on a denaturing polyacrylamide gel and vi-
sualized by autoradiography (22). Side-by-side comparison
of mRNA species from two or more related samples allows
identification of both up- and down-regulated genes.
In this paper, we describe the effects of cell cycling on
engraftment and transcript expression using highly purified
hematopoietic stem cells cultured in IL-3, IL-6, IL-11, and
steel factor.
 
Materials and Methods
 
Mice.
 
6 to 8 wk-old male or female BALB/c mice were
purchased from Taconic Farms and housed in a conventional
clean facility for at least 1 wk before experimental use. All ex-
periments were approved by the University of Massachusetts
and Roger Williams Medical Center Institutional Animal Care
and Use Committee.
 
All mice received mouse chow and acidified water ad libitum.
 
Hematopoietic Stem Cell Purification.
 
Bone marrow was iso-
lated from iliac bones, femur, and tibiae of BALB/c mice 6 to 8
wk of age. A low-density fraction (
 
 
 
1.077 g/cm2) was isolated
on Nycoprep 1.077A (Accurate Chemical and Scientific Corpo-
ration). These cells were lineage depleted by a magnetic bead
separation with the following antibodies: Ter119, B220, Mac-1,
GR-1, Lyt-2, L3t4, and YW25.12.7 and Dyna beads MW450
anti–rat IgG (Dynal). The lineage depleted cell were labeled with
Rhodamine 123 at a concentration of 0.1 mg/ml and Hoechst
33342 at 10 mM. Cells were incubated in the dark for 30 min at
37
 
 
 
C, washed, and followed by an additional warm buffer (37
 
 
 
C)
incubation for 20 min at 37
 
 
 
C to efflux the Rhodamine. This last
incubation was performed twice in some experiments before
sorting using FACS
 
®
 
. The 1st through the 13th percentiles of
Rhodamine fluorescence and 1st through the 3rd percentiles of
Hoechst fluorescence were isolated. This Lineage negative,
Rhodamine low and Hoechst low fraction is abbreviated LRH.
 
Cytokine Culture.
 
The LRH stem cells were cultured at an
initial density of 5,000 cells/ml in Dulbecco’s Modified Essential
Medium low glucose (Life Technologies/GIBCO BRL) contain-
ing 15% heat-inactivated fetal calf serum (HyClone Laboratories),
1% penicillin (100 U/ml)/1% streptomycin (100 mg/ml), and 1%
 
l
 
-glutamine (100 mg/ml). The cytokine cocktail used was rmIL-3,
50 U/ml (collaborative), rmIL-6, 50 U/ml (R&D Systems),
rhIL-11, 50 ng/ml (Genetics Institute), and rm steel factor, 50
ng/ml (SCF; R&D Systems). The LRH cells were cultured with
the above cytokines for 24 to 48 h in nonadherent Teflon bottles
in a humidified 5% CO
 
2
 
, 37
 
 
 
C water-jacketed incubator.
 
Autoradiographic Detection of 
 
3
 
H-thymidine–labeled Nuclei.
 
The
number of cells in S phase was determined by autoradiography of
the cells after pulse labeling with 
 
3
 
H-thymidine (17, 23). Briefly,
duplicate aliquots of cells (500 to 1,000), at 6-h intervals, as they
are progressing through cell cycle, were incubated with 2.5 
 
 
 
Ci/
ml of 
 
3
 
H-thymidine at 37
 
 
 
C in 5% CO
 
2
 
 containing humidified
incubator for 30 min. The incorporation of 
 
3
 
H-thymidine was
terminated by cytospin centrifugation and immediately fixing
with methanol/acetic acid (2:1 vol/vol), followed by three
washes in methanol. Slides were allowed to air dry overnight and
a thin film of Kodak nuclear track NTB3 emulsion (Eastman
Kodak Co.) was applied. Slides were then incubated in the dark
for 4 d, developed, and fixed with Kodak Decktol Developer and
Kodak Fixer, respectively. Slides were washed extensively and
stained with Giemsa. We determined the percentage of cells with
labeled nuclei (representing cells in S phase) by counting 200 cells
per slide. In addition, in order to estimate population doubling,
cell counts were determined using a hemocytometer.
 
Irradiation and Transplant.
 
Female mice were exposed to 10
Gy at a rate of 0.94–0.96 Gy/min in one fraction using a Cesium
137 gamma source (Gamma cell 40; MDS Nordian) at least two
hours before transplant. Donor mice were killed by cervical dis-
location. Bone marrow was isolated from femurs, tibias and iliac
bones with cold PBS. The cells were counted in a hemocytome-
ter, washed and resuspended for injection in PBS. For competi-
tive transplant, 250,000 female marrow cells were mixed with a
volume corresponding to 500 Lin
 
 
 
 Rh
 
low
 
 Ho
 
low
 
 cells initially in-
troduced into the culture vial.
 
Southern Blot Analysis of Engraftment.
 
DNA was extracted by
lysis in 150 mM NaCl, 20 mM Tris (pH 7.5), 20 mM EDTA, 1%
SDS, 0.5 mg/ml proteinase K, and 50 mg/ml pancreatic RNase
A at 55
 
 
 
C overnight. Purification was completed by organic ex-
traction with phenol-chloroform and ethanol precipitation. 5 
 
 
 
g
of each DNA sample was digested with DraI (Boehringer), andT
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separated by gel electrophoresis in 0.8% agarose (GIBCO BRL).
DNA fragments were alkaline transferred onto Zetaprobe nylon
membranes (Bio-Rad Laboratories). The presence of Y chromo-
some–specific DNA sequences was assessed using a pY2-cDNA
probe (24, 25; donated by Dr. I. Lemischka, Princeton Univer-
sity, Princeton, NJ). Sample loading variability was assessed and
adjusted for by reprobing membranes with a cDNA for IL-3 (do-
nated by J. Ihle, St. Jude Children’s Research Hospital, Memphis,
TN, and DNAX, Palo Alto, CA). Probes were labeled with 
 
32
 
P
using a random primed labeling kit (Boehringer), and autoradiog-
raphy was performed using Kodak XRP x-ray film (Eastern
Kodak Co.). Blots were exposed to PhosphorImaging plates (Mo-
lecular Dynamics), and the percentage of male and female DNA
quantified after scanning the plates with a 400A PhosphorImager
(Molecular Dynamics).
 
cDNA Preparation and PCR Amplification of cDNA 3
 
 
 
 Ends.
 
Poly A
 
 
 
 RNA was isolated from fresh or cultured cells using Oli-
gotex (QIAGEN). cDNA was generated using the Superscript
Choice System (GIBCO BRL; references 26 and 27). Briefly, 10
 
 
 
g of PolyA
 
 
 
 RNA and 2 pmol of 1 of the 2-base anchored
oligo(dT) primers with a heel sequence (20) were mixed with
other components for first-strand synthesis reaction. This was
followed by reverse transcription using 2 
 
 
 
l of Superscript re-
verse transcriptase (200 U/ml; Invitrogen/GIBCO BRL). Sec-
ond-strand synthesis was then performed and the cDNAs were
precipitated with ethanol. A Y-adaptor was assembled from 2
oligonucleotides with sequences TAGCGTCCGGCGCAGC-
GACGGCCAG and GATCCTGGCCGTCGGCTGTCTGTC-
GGCGC, respectively. The cDNA was digested with BglII and
an aliquot of this reaction mixture (
 
 
 
4 ng) was then used for liga-
tion to 100 ng of the Y-shaped adaptor. After ligation, the reac-
tion mixture was diluted with water, T4 ligase was denaturated at
65
 
 
 
 and aliquots were made for PCR amplification (28). The
primers used corresponded to the heel sequence for the 3
 
 
 
 end
and to one of the Y-adaptors for the 5
 
 
 
 end (TAGCGTCCG-
GCGCAGCGAC). The PCR products were identified on the
display gel by mixing a small proportion of [
 
 
 
32
 
P]ATP labeled 5
 
 
 
primer to the cold primer. PCR was performed with manual hot
 
start for 28–30 cycles of 94
 
 
 
C for 30 s, 56
 
 
 
C for 2 min, and 72
 
 
 
C
for 30 s. PCR products (2.5 
 
 
 
l) were analyzed on a 6% polyacryl-
amide sequencing gel. Bands of interest were extracted from the
display gels, reamplified using the 5
 
 
 
 and 3
 
 
 
 primers, and directly
sequenced or subcloned into pCR-Script using the PCR-Script
cloning kit (Stratagene). Sequencing was performed on an ABI
automated sequencer. A schematic of the procedure is presented
in Fig. 1.
 
Differential Display Analysis.
 
Each PCR was repeated 2–3
times and bands of interest were given a relative intensity from 0
to 9 by visual evaluation. The radioactive signal being carried by
the 5
 
 
 
 primer only, the size of the PCR product did not influence
the intensity grading. The information on each band was stored
into an Excel 2000 spread sheet (Microsoft). The sequences of
the bands were compared with public databases by BLAST
 
®
 
 anal-
ysis (29) and information on matching gene/sequence was col-
lected from NCBI website (30). The gene category was defined
based on these similarities.
 
Database Comparison and Graphical Representation.
 
The differ-
ential display of LRH, Lineage positive (Lin
 
 
 
), and LRH cultured
for 48 h (LRH 48) was compared by subtraction of each band in-
tensity and sorted according to the difference. Based on the inten-
sity of expression, a graphical representation was constructed us-
ing color-coded squares, each representing a unique cDNA
target. In this array, each gene was ordered according to the in-
tensity of the difference between two groups. Thus, an individual
gene can be visually compared between different cell populations,
their position on each array being the same. In addition this color
analysis allowed direct visual comparison of the entire subset of
genes to identify patterns. Specific genes represented in this pat-
tern analysis is available in supplementary data (see reference 30).
 
Data Availability.
 
Data can be assessed on line as follows:
open the following URL (http://info.med.yale.edu/genetics/
weiss/Linksfor_Hematon.htm) and then go to the “stem cells”
link. The total experimental information on gel analyses of RNA
Figure 1. Schematic description of 3  end differential display. cDNA
was prepared using a poly-T primer containing a 2-base anchor (5 ) and a
terminal heel (3 ). After restriction cut, the fragments were ligated to a
Y-adaptor and then amplified using primers homologous to one strand of
the Y-adaptor and to the heel sequence. The 3  end fragments are selec-
tively amplified by PCR and resolved on polyacrylamide gels. Separate
cell populations were directly compared and information on each band
relative intensity was stored and analyzed in an Excel™ database.
Figure 2. Engraftment defect through cell cycle. Male LRH cells were
cultured in IL-3, IL-6, IL-11, and steel factor for 0 to 48 h and competi-
tively transplanted with female bone marrow cells (ratio 1:500) in lethally
irradiated female recipients. Chimerism was measured 8 wk after transplan-
tation by Southern blotting using a Y-chromosome probe. In two experi-
ments, nadirs were observed at 36 and 48 h while a recovery was observed
at 40 h. These nadirs were statistically different compared with time 0 and
40 in both experiments (Exp. 1: P   0.01; Exp. 2: P   0.05). The cell cy-
cle status as determined by 3H-thymidine pulse labeling and cell counts
and population doubling of cultured LRH cell is shown at the bottom.
The two nadirs coincided with the late S/early G2 phase of cell cycle.T
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expression is collected in a Microsoft Access database with a sepa-
rate sheet for each gel band that was analyzed.
 
Results
 
Engraftment Defect Through Cell Cycle.
 
In two separate
experiments, LRH stem cells were evaluated for engraft-
ability at 8 wk in a competitive transplant model. The ini-
tial engraftment level was 50 
 
 
 
 1% and 39 
 
 
 
 4% for fresh
LRH cells. Two nadirs of engraftment were observed at 36
and 48 h of culture in IL-3, IL-6, IL-11, and steel factor.
The chimerism was 10 
 
 
 
 2 and 13 
 
 
 
 1 at 36 h and 4 
 
 
 
 1
and 12 
 
 
 
 2 at 48 h. A recovery of engraftment was ob-
served at 40 h (Fig. 2). In a separate experiment, LRH stem
cells, cultured in the same cytokines, were mapped for cell
cycle by 
 
3
 
H-thymidine pulse labeling and cell count dou-
bling. Cell cycle status is shown in the bottom of Fig. 2.
These data indicate that engraftment nadirs occurred dur-
ing late S/early G
 
2
 
.
 
LRH Specific Genes.
 
PCR amplification of the cDNA
3
 
 
 
 ends was performed using a Y-adaptor ligated to restric-
tion fragments of the cDNA mixture (see Fig. 1). Gene ex-
pression of LRH stem cells and lineage positive (Lin
 
 
 
)
fraction was compared by differential display. A total of
637 genes were expressed only in LRH cells. They were
all subcloned and sequenced. Among these genes, 411
 
Table I.
 
Stem Cell–specific cDNAs Expressed in LRH but Not In Lin
 
 
 
 Cells
 
Transcription factors Translational Apparatus
Human ribosomal protein L18A
Murine homeobox protein zhx-1 Human RNA helicase-like protein
Mouse TAX1 binding protein Mouse protein synthesis elongation factor Tu
Mouse translational controlled 40 kDA polypeptide p40
Mouse protein tyrosine kinase in Lin
 
 
 
 CD34
 
 
 
 Sca
 
 
 
hematopoietic progenitors
Mouse whn transcription factor
Energy metabolism
R25908NOT a human immediate-early response gene
closely related to the 
 
  
 
transcription factors Mouse NADH-ubiquinone oxidoreductase
Mouse cytoplasmic gamma-actin
Cytokine
Mouse hepatoma derived growth factor RNA m
Mouse heparin-binding EGF-like Mouse hematopoietic lineage switch 2 (HLS2)
Growth factor (HB-EGF), exons 5-6 Human splicing factor arginine/serine-rich 7 (SFRS7)
Signaling pathway Chromatin
Mouse putative E1-E2 ATPase Mouse HMG1-related DNA binding protein
Mouse PSMB5
Human CD9 Membrane trafficking
Mouse eukaryotic translation 
Surface proteins
(previous line)Initiation factor 3 (new item)
rat RAB14 protein
Mouse bullous pemphigoid antigen 1-b (Bpag 1)
Receptor
Cell cycle regulation Mouse inositol 1, 4, 5-triphosphate receptor
Human hypothetical protein FLJ10439
Mouse c-yes tyrosine protein kinase Apoptosis regulation
Mouse casein kinase II, beta subunit Mouse aspartate aminotransferase
Mouse Ercc-4 DNA repair gene
Mouse G protein beta subunit homologue
These represent specific genes expressed in LRH at a score of 6 or above and not expressed in Lin
 
 
 
 cells. 
The number of genes expressed in LRH at any score and not in Lin
 
 
 
 cells is as follows: transcription factors 22, protein synthesis 11, surface protein
11, mitochondrial sequence 10, RNA metabolism 10, signaling pathway 9, cytokine 8, membrane trafficking 8, cytoskeleton 7, chromatin 5,
metabolism 5, cell cycle regulation 4, energy metabolism 4, adhesion molecule 3, apoptosis regulation 2, lineage switch 2, secreted protein 2,
translational apparatus 2, acid base regulation 1.T
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were unknown with no homologies to GenBank data-
bases. There were 226 cDNA with homologies to Gen-
Bank databases and 126 of these corresponded to genes
with known function. The large number of transcripts not
associated with known genes is noteworthy. Very recent
studies using genomic “tiling” arrays have shown that a
much larger portion of the genome is transcriptionally ac-
tive than would have been predicted from the presence of
known or putative genes (31). The known genes belonged
to 19 different gene categories (footnote, Table I).
Specific genes highly expressed in LRH (score of 6 or
above) and not expressed in Lin
 
 
 
 are presented in Table I.
An alignment of LRH and Lin
 
 
 
 genes is presented in
Fig. 3.
 
LRH Gene Expression Shifts Through Cell Cycle.
 
To
evaluate gene expression through cytokine-induced cell
cycle, we prepared cDNA from LRH cells incubated in
Teflon bottles for 0 or 48 h with IL-3, IL-6, IL-11, and
steel factor (LRH48). 251 transcripts from fresh LRH cells
or Lin
 
 
 
 cells were chosen for analysis based on their differ-
ential expression patterns. A major shift in gene expression
was found with many genes active in LRH but turned off
in LRH48 and other genes inactive in LRH turned on in
LRH48 (Fig. 4). Analyzing the difference of gene expres-
sion between LRH and LRH48, we made a comparison of
expression levels between baseline and 48 h of culture.
Genes were sorted according to their difference in level of
expression with a minimal difference of 4. A total 89
cDNA’s were turned off at 48 h of culture with a residual
expression level
 
 
 
 
 
2.
 
 
 
These genes, related to noncycling
cells are defined as quiescent. Out of these cDNAs, we
found 51 sequences with similarities to GenBank. Table II
Figure 3. Dot matrix comparison of LRH
and Lin  cells. A total of 929 cDNA’s were
evaluated by direct comparison of LRH and
Lin  expression pattern by differential display.
The intensity of each band was color-coded to
represent each gene product as a squared-dot.
The dot matrix is sorted according to the differ-
ence of intensity between LRH and Lin . 637
genes were expressed only in LRH cells. Each
specific dot can be further identified in the ad-
ditional materials [www.jem.org] using the
matrix coordinates (column A to BJ and row 1
to 15). For example, the red dot located in the
first third of the LRH matrix at position W11
represent a cDNA homologous to the rat ribo-
somal protein S7 (GenBank accession no.
X53377). Note that gray pixels represent blanks.
Figure 4. Matrix comparison of LRH,
LRH48, and Lin  gene expression A total of
252 targets are presented. The approach is as
outlined above in the legend for Fig. 3. Note
that gray pixel represents a blank.T
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describes 28 genes whose name and function are known. A
total of 39 cDNA were turned on at 48 h from a baseline
expression level  2. These genes, termed cycling represent
25 sequences with homologies to the GenBank database
and 14 known genes (Table III). A few cDNA’s (29) had a
stable expression through cycle, while not expressed in
Lineage  cells. These represent 18 genes with similarities
and 13 known genes (Table III, common genes). The gene
shift seen here probably did not represent differentiation, as
gene expression was dramatically different between the 48 h
group and the differentiated lineage  cells.
Discussion
Previous work by our laboratory has demonstrated that
cytokine stimulated unseparated whole bone marrow cells
developed an engraftment defect occurring during the late
S/early G2 of cell cycle. Others have also shown cell cycle
associated changes in stem cell phenotype. Studying Lin 
Sca-1  Thy1low through cell cycle, Fleming et al. (32)
showed decreased engraftment in S/G2/M as compared
with G1. In a similar vein, Lin  Sca-1  cells, selected based
on Hoechst staining, were found to have long term en-
graftment potential only when in G0/G1 and not when in
S/G2/M (33). We have also recently shown that purified
stem cells (Lin  Sca-1 ) evidenced a homing defect coinci-
dent with the timing of an engraftment defect (2). In addi-
tion, work in collaboration with Dr. Pamela Becker,
showed a major fluctuation of cell surface adhesion mole-
cules on LRH cells during cell cycle passage (4). Here, us-
ing highly purified murine marrow hematopoietic stem
cells, we have confirmed a reversible fluctuation of engraft-
ment through cell cycle, with a comparable timing as was
seen with studies on unseparated marrow cells. The en-
graftment potential was followed for two cell divisions and
fluctuation was reproducibly observed.
Using a nonselective approach with differential display
analysis, we were able to identify over 600 stem cell genes,
most of these being actively expressed in relatively “quies-
cent” stem cells selected on the base of their quiescent sta-
tus. The gene machinery is highly active. Previous studies
have also shown that LRH cells can move extremely rap-
idly, thus further negating the dogma that these cells are
metabolically inactive (6). 
The 48 h culture time point, showing a major engraft-
ment defect, was chosen for analysis of the pattern of LRH
gene expression. A major shift of gene expression was dem-
onstrated. Compared with time zero (i.e., fresh LRH), the
cells cultured for 48 h had turned down most of the highly
expressed genes and turned on most of the genes initially
not or faintly expressed. From these data, we can postulate
that many genes necessary for engraftment or initial hom-
ing are turned off during cell division, thus possibly ex-
plaining the observed engraftment defect. A number of
genes were turned on and it is unknown whether these
genes participate in altering homing and engraftment. In
contrast, many genes were comparably expressed in both
LRH and LRH48 cells, defining a pattern of stem cell spe-
cific genes whose expression does not seem to be modified
by cycling. When comparing the categories of genes ex-
pressed in LRH and in LRH48 cells, the “quiescent” genes
are mainly transcription factors and protein synthesis genes,
while “cycling genes” are related to cell cycle regulation
and chromatin remodeling.
When comparing the same panel of genes with Lin 
cells, we noted a completely different picture; the genes
turned on during cell cycle were not expressed in Lin  cells
with a few exceptions such as Histone H2A gene (see Ta-
ble III), active in both cycling LRH48 and Lin  but not in
fresh LRH. This pattern thus suggests cell cycle specificity
and is fundamentally different from lineage differentiation.
This weighs strongly against the hypothesis that cell cycle
engraftment defect could be related to lineage differentia-
tion. However, it must be acknowledged that some of the
genes turned on and expressed at 48 h could represent an
early onset of differentiation, as the gene expression profile
of cells early in differentiation might be different from that
seen in fully differentiated cells such as are represented by
lineage positive cells. This seems unlikely to us, but will
only be resolved with experiments showing reversibility of
these gene changes.
These results show a major shift in gene expression of
purified marrow stem cells at a time when engraftment is
markedly and reversibly depressed. It is difficult to assign
specific roles to individual genes, given the relatively large
number that are turned on or off and given the presence of
a number of unknowns. Genes turned on at 48 h of culture
include those involved in DNA damage repair (34–36),
chromatin modification (37, 38), RNA splicing (39), and
intracellular signaling (40, 41). Several genes could be in-
volved in cell–cell and cell–matrix interactions, adhesion
Table II. Differential Expression Comparing cDNAs from LRH 
and LRH 48 Cells
Genes with high expression
in LRH
Genes with high expression
in LRH48
Gene category No. Gene category No.
Transcription factors 4 Cell cycle regulation 4
Protein synthesis 4 Chromatin 3
Mitochondrial seq. 4 Lineage differentiation 2
Cytoskeleton 3 Transcription factors 2
RNA metabolism 3 Apoptosis 1
Metabolism 3 DNA replication 1
Surface protein 2 Membrane trafficking 1
Cytokine 1 RNA maturation 1
Membrane trafficking 1 Secreted protein 1
Receptor 1
Signaling pathway 1
Translation apparatus 1T
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Table III. Known Genes Turned Off During Cycle (Quiescent), Conserved through Cycle (Stem Cell Specific), or Turned On at 48 h of 
Culture (Cycling Genes)
ID no. GenBank match Access no. Size LRH* LRH48**
Quiescent genes
2626 Human TBP-associated factor 170 AJ001017 186 6 0
2606 Mouse antigen peptide transporter 1 AF027865 331 6 0
2683 Mouse aspartate aminotransferase X07309 130 6 0
2687 Mouse A-X actin J04181 149 6 0
2742 Mouse bullous pemphigoid antigen 1-b (Bpag1) AF396879 344 6 0
2597 Mouse elongation factor 1-alpha X13661 118 6 0
2634 Mouse inositol 1,4,5-trisphosphate receptor Z71173 234 6 0
2604 Mouse PSMB5 AB003306 265 6 0
2663 Mouse spermophilus tridecemlineatus 26s proteasome U36395 391 6 0
2717 Mouse translation initiation factor 4E M61731 162 6 0
2718 Human splicing factor, arginine/serine-rich 7 (SFRS7) L41887 178 6 2
2681 Mouse putative E1-E2 ATPase AF011336 470 6 2
2648 Human memd U31000 350 4 0
2602 Human splicing factor Sip1 AF030234 249 4 0
2654 Mouse 84 kD heat shock protein M18186 350 4 0
2698 Mouse cholesterol 7-a-hydroxylase exon 1 Z18860 174 4 0
2588 Mouse GU protein AA272436 253 4 0
2689 Mouse heat shock protein 70 cognate U27129 196 4 0
2585 Mouse inositol 1,4,5-triphosphate receptor 5 Z33908 237 4 0
2771 Mouse interleukin-5 X06271 292 4 0
2600 Mouse mitochondrial 12S ribosomal RNA X84382 210 4 0
2772 Mouse mitochondrial genome V00711 77 4 0
2719 Mouse pim-1 proto-oncogene M13945 192 4 0
2624 Mouse protein synthesis elongation factor Tu M22432 364 4 0
2799 Mouse retinoblastoma binding protein 2 AC018559 153 4 0
2615 Mouse ribosomal protein S12 X15962 142 4 0
2806 Mouse signal recognition particle receptor beta subunit AA419748 220 4 0
2647 Mouse T cell receptor gamma locus (gamma 2 and 4 gene clusters) AF021335 267 4 0
2761 Rat androgen-binding protein M19993 272 4 0
Common genes
2677 Mouse Ercc-4 DNA repair gene AC004155 365 6 4
2805 Human ribosomal protein L18A L05093 41 6 4
2594 Mouse TIE receptor tyrosine kinase X73960 364 6 4
2571 Mouse ribosomal protein S20 X51537 150 6 4
2573 Mouse jerky mRNA U35730 164 8 8
2633 Mouse casein kinase II, beta subunit X80685 189 6 6
2744 Human CD9 L08115 156 6 6
2595 Mouse protein synthesis elongation factor Tu M22432 375 6 6
2608 Mouse antigen peptide transporter 1 AF027865 372 6 6
2582 Rat matrin cyclophilin AF043642 203 4 4
2569 Mouse ribosomal protein S12 X15962 146 4 4
2727 Rat 3-hydroxyiso- butyrate J04628 270 4 6
2671 Mouse heat shock protein 70 cognate M19141 587 4 6
Cycling genes
2674 Mouse excision repair cross-complementing rodent repair deficiency, complementation group 2 L47235 223 0 4
2631 SWI/SNF related transcription termination factor, RNA polymerase II AA311008 275 0 4
2568 Rat matrin cyclophilin AF043642 149 0 4
2575 CCR4-NOT transcription complex, subunit 7 AA816074 198 0 4
2705 Mouse G-utrophin X83506 450 0 4
2711 Human HS1 heamatopoietic protein X16663 123 0 4
2596 Myeloid cell-specific leucine-rich glycoprotein (CD14) AC087795 390 2 8
2644 Mouse transcription elongation factor S-II-T1 D86081 206 0 6
2696 Mouse beta-1,4-galactosyltransferase D37791 136 0 6
2572 Mouse MAP1 AA396150 156 0 6
2743 Mouse cell division control protein 19 D86725 363 0 6
2750 Rat basement membrane-associated chondroitin proteoglycan Bamacan U82626 272 0 6
2754 H2A Histone family, member Y C75971 304 2 8
2592 MUS81 endonuclease AA014278 280 0 8
Relative expression in LRH cells* or LRH48 cells**.T
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and cell migration. These are rat basement membrane-asso-
ciated chondroitin proteoglycan BAMacan (42), mouse cell
division control protein 19 (43), and mouse  -1,4-galacto-
syltransferase (44, 45). The latter appears to be important in
cytoskeletal assembly and lamellipodia stability and “mes-
enchymal cell migration on basal lamina”. Expression of
these particular genes could indicate changes in stem cell
migration/homing patterns which could negatively effect
marrow stem cell engraftment. In a similar vein, genes
which are turned off could adversely effect stem cell en-
graftment into the marrow cavity. Many maintenance
genes are turned off and their effects on proliferation and
survival could determine ultimate engraftment outcomes.
Human MEMD is turned off, and this gene appears to play
a role in cell–cell interactions and in migration of mobile
cells through tissues (46). Thus, turning off of this gene
could also have effects in influencing marrow homing. Al-
together the observed engraftment defect is likely to be due
to polygenic changes.
Recent studies in our laboratory have indicated that
when marrow homing is depressed, stem cells are diverted
to other nonmarrow tissues, such as lung (47). Alterations
of expression of different migration/adhesion factors thus
may be involved in such stem cell diversions. This is, of
course, only one of many possibilities. A fuller understand-
ing will have to await knockout (embryonic or siRNA
adult) studies of individual gene function and identification
of the unknown genes.
The modulation of gene expression is consistent with
previous observations of modulation of both adhesion pro-
teins and cytokine receptor expression (4, 48). The obser-
vations that primitive stem cells are continuously, if inter-
mittently, passing through cell cycle suggests that their
phenotype is probably continuously changing.
During cell cycle progression, chromatin is remodeled.
In previous studies, chromatin modulations at the  -globin
and lysozyme gene loci were evaluated (49–52). Myeloid
specific cis-regulatory elements showed a specific chroma-
tin pattern at the lysozyme locus in myelomonocytic cells
at different differentiation stages. This chromatin pattern
was also found in multipotent hematopoietic progenitors,
but was no longer apparent with erythroid differentiation.
Studies of multipotent hematopoietic stem cell chroma-
tin structure showed that the lineage associated genes,
globin, myeloperoxidase, IgH, and CD3  have accessible
control regions before unilineage commitment (50–54).
Other studies suggest that chromatin remodeling factors re-
cruited in one phase of cell cycle may determine ultimate
action in a later phase. This in turn would determine
changes in transcriptional programs (55). A reasonable se-
quence of events for stem cell phenotype regulation is
chromatin remodeling with cytokine induced cell cycle
passage, leading to varying levels of transcription factor ac-
cess to DNA, followed by alteration in gene expression.
Thus, these events would prime a stem cell to respond to a
specific signal. If the signal was not delivered, the stem cells
would again change phenotype. For example, Notch is
probably an important primitive stem cell surface receptor.
If Notch expression was augmented or present and the
stem cell did not see the appropriate ligand, the moment of
opportunity would pass and the cell would then be respon-
sive to different signals (56, 57). If, however the cell saw its
ligand, ragged-1, on a stromal cell, a sequence of events
would follow with activation of PU.1 and induction of
myeloid differentiation (58, 59). 
In summary, using highly purified murine HSC, we
have shown a major shift of gene expression between two
specific functional states. Thus, noncycling HSC selectively
express mainly transcription regulators and protein synthe-
sis factors, while they are fully capable of repopulating a
myeloablated transplant recipient. In contrast, cells in S/G2
have turned down most of the originally active genes, and
now express cell cycle related as well as chromatin remod-
eling genes. This indicates a stem cell phenotype that is
continuously changing its potential over time, while HSC
slowly travel through the cell cycle.
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